Lisa Miller

After publishing them in October 2016,the National Comprehensive Cancer Network (NCCN) is already seeking to update and expand their guidelines for diagnosing and treating patients with myeloproliferative neoplasms (MPNs).

Patients with metastatic kidney cancer may see a decreased efficacy of their immunotherapy regimen if they recently took antibiotics.

There is a need for more targeted clinical trials for patients with ALL, since many of them have Philadelphia chromosome (Ph)-like acute lymphoblastic leukemia.

Three recent trials showed that Keytruda had a durable response for patients with a rare subtype of melanoma.

The combination of onartuzumab and Avastin (bevacizumab) showed no additional benefit for patients with glioblastoma, according to a recent study.

Women who are experiencing symptoms of menopause often mistake those events as treatment side effects, leading to a decrease in adherence.

A subset of patients with breast cancer saw an increase in progression-free survival with the addition of Afinitor to Faslodex.

Patients with DNA mismatch repair deficiency rectal cancer may not necessarily have Lynch syndrome. Expert Yi-Qian Nancy You weighs in on the topic.